Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Jiangsu Simcere Pharmaceutical identifies new PRMT5 inhibitors

June 1, 2021

Nerviano Medical Sciences patents IDH inhibitors

June 1, 2021

Nanjing Ruijie Pharma divulges ACC inhibitors

June 1, 2021

AbbVie initiates first-in-human study of ABBV-623 and ABBV-992

June 1, 2021

Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo

June 1, 2021

Disulfiram/copper gluconate studied in phase I for treatment-refractory multiple myeloma

May 31, 2021

RNF6 and SF3B2 are novel therapeutic targets in colorectal cancer

May 31, 2021

BPRCX-807 demonstrates promising activity in models of HCC

May 31, 2021

Nanjing Sanhome Pharmaceutical synthesizes PTPN11 inhibitors

May 31, 2021

Guangzhou Henovcom Bioscience patents ENPP2 inhibitors

May 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...